Dublin, Sept. 25, 2017 -- The "Healthcare Markets for Medical Microneedles" report has been added to Research and Markets' offering.
Advances in materials processing - technologies that include micromachining, nanoprocessing and structured film forming - are creating new devices and new opportunities for minimally invasive medicine.
The processing techniques incorporate one or more technologies that enable the precise machining, extrusion, casting, and/or forming of from one to an array or grid of microneedles.
Microneedle technology has the potential to address the growing trend toward minimally invasive medicine by allowing the precise delivery of therapeutic agents to prescribed locations below the skin. Microneedles will also be a factor in continuous and ambulatory patient monitors and point-of-care diagnostics.
What You Will Learn
- What are the recent developments in the area of medical microneedles? What medical applications and markets do they address?
- How has technology evolved to advance the addressable market for medical microneedles?
- What are the major factors driving development activity and investment in the medical microneedle segment?
- What are the emerging therapeutic and diagnostic applications that are expected to drive growth in medical microneedle markets?
- What is the size of the market today, who are the market share leaders, and what will the market share be in 2024?
- How important are drug developer-device manufacturer relationships and what are the key alliances in the industry?
Report Value Matrix - Who should read this report
- Managed Care Managers
- Management Consultants
- Financial Analysts
- Pharma Product Managers
- Device Suppliers
- Biotech Managers
- Drug Marketers & Strategists
- Product Developers
- Component Suppliers
- CMOs, CSOs
- Clinical Managers
- Drug Distributors
- Pharma Regulators
Key Topics Covered:
1. Executive Summary
2. Patient Care Dynamics
3. The Informed Patient
- Healthcare Demand Drivers
- Aging Population Demographics
- Chronic Conditions
- Wearable Devices
- Connectivity
- Patient Self-care
- Healthcare Economics
- Market Drivers
- Risk Factors
4. Microneedle Device Technology
- Design Factors
- Material Selection
- Fabrication Methods
- Additive Manufacturing
- 3D Printing
- InkJet
- Electrospun Arrays
- Electrodeposition
- Magnetization-induced Self-assembly
- Microneedle Architectures
- Array Architectures
- Microneedle Form Factors
- Solid Microneedles
- Coated Microneedles
- Hollow Microneedles
- Carbon Nanotubes
- Ion Etching
- C-MEMS
- Electrolyte Sensing
- Dissolving Microneedles
- Hydrogels
- Polymers
- Other Organic Molecules
- Specialty Microneedles
- Phase Transition
- Microprocessor-based
- Composite Microneedles
- Light-responsive Microneedles
- Flexible Arrays
- Nanocarrier Arrays
- Microneedles & Microfluidics
- Wearable Microneedles
5. Medical Microneedle Markets & Forecasts
6. Diagnostics
- Biosensing
- POC Testing
- Antigen Testing
- Drug Delivery
- Intradermal
- Microporation
- Transdermal
- Applications
- Local Anesthesia
- Vaccines
- Peptides
- Electrosurgical
- Patient Monitoring
- Interstitial Fluid Sampling
- Immune System Monitoring
- Glucose
- Antibiotics
- Analyte Monitoring
- Neurology
- Dermatology
- Hematology
- Sampling
- Blood Sampling
- Therapeutic
- Immunotherapy
- Electrotherapy
- Gene Therapy
Company Profiles
- 3M
- Becton Dickinson
- Corium
- Debiotech
- MEDRx
- microLIQUID
- Micropoint Technologies
- MyLife Technologies
- NanoPass
- Nemaura
- PKA SoftTouch
- Radius Health
- Sanofi-Aventis
- Syneron
- TheraJect
- TransDerm
- Valeritas
- Zosano Pharma
For more information about this report visit https://www.researchandmarkets.com/research/94j6dp/healthcare
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Healthcare Services, Infusions and Injectables , Needles and Syringes


AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market
BP Nears $10 Billion Castrol Stake Sale to Stonepeak
Nvidia and Groq Strike Strategic AI Inference Licensing Deal
ByteDance Plans Massive AI Investment in 2026 to Close Gap With U.S. Tech Giants
Hanwha Signals Readiness to Build Nuclear-Powered Submarines at Philly Shipyard for U.S. Navy
Texas App Store Age Verification Law Blocked by Federal Judge in First Amendment Ruling
Boeing Wins $2.04B U.S. Air Force Contract for B-52 Engine Replacement Program
Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies
Waymo Plans Safety and Emergency Response Upgrades After San Francisco Robotaxi Disruptions
Mexico Antitrust Review of Viva Aerobus–Volaris Deal Signals Growth for Airline Sector
Warner Bros. Discovery Shares Slide Amid Report of Potential Paramount Skydance Lawsuit
South Korean Court Clears Korea Zinc’s $7.4 Billion U.S. Smelter Project, Shares Surge
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement
Nike Stock Jumps After Apple CEO Tim Cook Buys $2.9M Worth of Shares
Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown 



